LONG MINI-FUTURE - ZOETIS Share Price

Certificat

DE000VD2ZRL3

Real-time Bid/Ask 16:58:33 11/07/2024 BST
3.88 EUR / 3.9 EUR +9.89% Intraday chart for LONG MINI-FUTURE - ZOETIS
Current month-2.75%
1 month-14.90%
Date Price Change
11/07/24 3.88 +9.60%
10/07/24 3.54 -3.01%
09/07/24 3.65 -3.69%
08/07/24 3.79 +1.07%
05/07/24 3.75 -0.79%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 04:43 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ZOETIS INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD2ZRL
ISINDE000VD2ZRL3
Date issued 27/03/2024
Strike 135.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.29
Lowest since issue 1.19
Spread 0.02
Spread %0.52%

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
173.5 USD
Average target price
210.2 USD
Spread / Average Target
+21.13%
Consensus